Diabetes eye screen delays may increase risk of vision loss

Credit: Unsplash+

Diabetic eye disease, particularly diabetic retinopathy, is a significant concern for people with diabetes. This condition can lead to vision impairment and even blindness if not detected and treated early.

Routine eye screening plays a crucial role in identifying and managing diabetic eye disease.

In England, the National Health Service (NHS) has established a screening program to monitor patients for this condition.

However, recent research raises concerns about the potential impact of extending the screening interval for certain groups of patients.

The Importance of Early Detection

Diabetic eye disease, especially diabetic retinopathy, can progress rapidly and cause severe vision problems. Early detection is vital because it allows for timely intervention and treatment, preventing further damage and potential sight loss.

The goal of the NHS screening program is to identify these eye problems early to ensure that patients receive appropriate care promptly.

In 2003, the NHS in England introduced the Diabetic Eye Screening Program (DESP) for individuals with type 1 or type 2 diabetes aged 12 and older.

This program aimed to detect diabetic eye disease, which results from damage to the small blood vessels at the back of the eye. Early treatment is essential to prevent vision loss.

Changing Screening Frequencies

The UK National Screening Committee recommended a change in screening frequencies in 2016. Under the new guidelines, individuals at high risk of sight loss should undergo annual eye checks, while those considered low risk would have eye checks every two years.

This adjustment was made to address increasing demand while maintaining cost-effectiveness.

To assess the impact of these changes, researchers conducted a study using one of the largest and most ethnically diverse diabetic screening programs in North East London.

The study included 82,782 people with diabetes who had no diabetic eye disease during two consecutive screens between 2012 and 2021.

Over the eight-year study period, 1,788 new cases of moderate to severe (sight-threatening) diabetic eye disease were identified in individuals considered to be at low risk.

These cases included 103 with proliferative diabetic retinopathy (PDR), the most severe form associated with a high risk of blindness.

The study found significant differences among ethnic groups. Black individuals were 121% more likely to develop sight-threatening diabetic eye disease than white individuals, while South Asian individuals were 54% more likely.

Implications of Extending Screening Intervals

Extending the screening interval to two years instead of annually could result in delays in diagnosing diabetic eye disease.

For over half of those with sight-threatening disease (56.5%) and nearly half of those with PDR (44%), diagnosis would be delayed by 12 months.

These delays were more pronounced among Black individuals and younger (under 45) and older (65+) age groups. This suggests that certain populations may experience a greater negative impact from extending screening intervals.

The study’s findings raise concerns about potential health inequalities resulting from extended screening intervals.

While the aim of biennial screening is to reduce the burden on patients and the NHS, it’s essential to address the risk of exacerbating health disparities, particularly among ethnic and age groups.

Conclusion: Balancing Efficiency and Equity in Diabetic Eye Screening

The study highlights the importance of carefully considering the impact of changes in diabetic eye screening intervals.

While extending the interval may offer practical benefits, it’s crucial to ensure that vulnerable populations, including ethnic and age groups, do not face increased risks of sight loss due to delayed diagnosis.

Balancing efficiency with equity is essential in diabetes care, and ongoing monitoring and adjustments to screening programs are needed to address these challenges effectively.

If you care about eye health, please read studies about how vitamin B may help fight vision loss, and MIND diet may reduce risk of vision loss disease.

For more information about eye disease, please see recent studies about how to protect your eyes from glaucoma, and results showing this eye surgery may reduce dementia risk.

The research findings can be found in the British Journal of Ophthalmology.

Follow us on Twitter for more articles about this topic.

Copyright © 2023 Knowridge Science Report. All rights reserved.